Related Experiment Video
Updated: Jun 27, 2026
12:14
CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
Published on: June 2, 2022
Chemokines in neuroectodermal tumour progression and metastasis
Lizzia Raffaghello1, Claudia Cocco, Maria Valeria Corrias
1Laboratory of Oncology, G. Gaslini Institute, Largo Gerolamo Gaslini 5, 16147 Genova, Italy.
Seminars in Cancer Biology
|November 18, 2008
Summary
Chemokines and their receptors are key to neuroectodermal tumor metastasis. This review highlights their roles in neuroblastoma, melanoma, and small cell lung cancer, focusing on specific chemokine pathways.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Chemokines and their receptors are crucial in regulating tumor progression and metastasis.
- Neuroectodermal tumors, including neuroblastoma, melanoma, and small cell lung cancer, exhibit complex interactions with the immune microenvironment.
- Understanding these interactions is vital for developing targeted therapies.
Purpose of the Study:
- To review current knowledge on chemokines and receptors involved in neuroectodermal tumor metastasis.
- To emphasize the role of these molecules in neuroblastoma, including the CXCR4/CXCL12 axis and tumor-derived chemokines.
- To discuss chemokine involvement in adult neuroectodermal tumors like melanoma and small cell lung cancer.
Main Methods:
- Literature review of scientific articles on chemokines, receptors, and neuroectodermal tumors.
- Analysis of studies focusing on neuroblastoma metastasis and immune cell infiltration.
- Comparative discussion of chemokine roles in neuroblastoma, melanoma, and small cell lung cancer.
Main Results:
- The CXCR4/CXCL12 axis has a complex and debated role in neuroblastoma bone marrow localization.
- Neuroblastoma-secreted chemokines like CCL2 and CX3CL1 can recruit lymphoid cells to the tumor site.
- Chemokine receptor expression and function vary across different neuroectodermal tumors.
Conclusions:
- Chemokines and their receptors are significant regulators of neuroectodermal tumor metastasis.
- Targeting specific chemokine pathways presents potential therapeutic strategies for these cancers.
- Further research is needed to elucidate the precise roles of chemokines in different neuroectodermal tumor types.
Related Concept Videos
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:21Chemotaxis and Direction of Cell Migration
Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon towards...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...